SOM Biotech announces poster presentation on the repurposing of Eravacycline for the treatment of SARS-CoV-2

by Som Biotech

SOM Biotech announces today that it will present in silico and in vitro results regarding Eravacycline for the treatment of SARS-CoV-2 during a virtual poster presentation at the IDWeek 2020.

Read more

ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadademstat in leukemia

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces the p...

Read more

Metoprolol: an old drug with unique cardioprotective properties

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

CNIC scientists have defined the unique ability if metoprolol to protect the heart during a heart attack

Read more

Promega Developing OncoMate™ MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate from Incyte

by Promega Biotech Ibérica

Promega Corporation announced today its intent to develop the Promega OncoMate™ microsatellite instability (MSI) Assay as a companion diagnostic test for retifanlimab, Incyte’s anti-PD-1 drug cand...

Read more

Palobiofarma announces positive results from the Phase II clinical trial evaluating the preliminary efficacy and safety of its adenosine A1 receptor antagonist PBF-680 in mild to moderate asthmatics patients

by Palobiofarma

The results confirm a clinically and statistically significant improvement in trough FEV1 of asthmatic patients taking 10mg of PBF-680 for 14 days compared to placebo.

Read more

Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis

by Galchimia

We are happy to share our latest report from the work carried out in collaboration with GlaxoSmithKline and the Drug Discovery Unit of the University of Dundee. The paper published in RSC Medicinal Ch...

Read more

SOM Biotech is awarded a grant from CDTI to start clinical trials with a drug inhibitor of SARS- COV-2 replication

by Som Biotech

SOM B​iotechhas been granted €340,000.00 from the Center for Industrial Te​chnological Development (CDTI, Spain), within the extraordinary call for grants for R&D projects to face the COVID-19 h...

Read more

Promising drug against non-alcoholic steatohepatitis, a severe type of liver disease

by Fundació Bosch i Gimpera

Nonalcoholic steatohepatitis (NASH) affects 2 to 5 percent of the world’s population. It is the most severe form of fatty liver disease, which can lead to cirrhosis, among other complications, and i...

Read more

Hope for a new treatment for the autoimmune neuromuscular disease Myasthenia Gravis (MG)

by 3P Biopharmaceuticals

3P Biopharmaceu​ticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, together with Toleranzia, a Swedi...

Read more

UdL, IRBLleida and HUAV initiate a research study to evaluate the efficacy of chloroquine treatment against COVID-19

by IRB Lleida. Institut de Recerca Biomèdica

The professor and researcher at the UdL and the IRBLleida Joan Fibla, the doctor from the HUAV Emergency Service Oriol Yuguero and the UdL researcher Marina Laplana lead the project, which will be car...

Read more

Researchers at IBEC help identifying a drug in clinical phase that blocks the effects of SARS-Co-V2

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researchers led by ICREA Research Professor Núria Montserrat, together with international collaborators, have identified a drug capable of blocking the effects of the SARS-Co-V2 virus, the origi...

Read more

An alternative drug to antibiotics receives the boost from the CaixaImpulse Consolidate program

by Hospital Universitari de Bellvitge

An alternative to the use of antibiotics created by the group of Dr. Rafael Mañez, from the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital (HUB), has been sel...

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

The Bigas Lab finds Notch self-inhibitio...

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

It has been found that the population of haematopoietic stem cells (HS...

Photos Stream